The Role of Interleukin-18 in the Development and Progression of Atherosclerosis

(E-pub Ahead of Print)

Author(s): Afsane Bahrami, Thozhukat Sathyapalan, Amirhossein Sahebkar*

Journal Name: Current Medicinal Chemistry

Become EABM
Become Reviewer


Atherosclerosis (AS) as a chronic inflammatory disorder of the cardiovascular system, is one of the leading cause of ischemic heart disease, stroke and peripheral vascular disease. There is growing evidence on the role of innate and adaptive immunity in the pathogenesis of atherosclerosis. Interleukin-18 is one of the novel proinflammatory cytokines involved in the atherogenesis, atherosclerotic plaque instability and plaque rupture. In this review, we overview the findings of the preclinical and clinical studies about the role and mechanism of action of IL-18 in the pathogenesis of AS, which could offer novel prognostic and therapeutic approaches.

Keywords: matrix metalloproteases, acute coronary syndromes, vascular smooth muscle cells, Polymorphism

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/0929867327666200427095830
Price: $95

Article Metrics

PDF: 2